Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Urol
    July 2021
  1. SHIN T, Mimata H
    "Early-pull-out" technique for intracorporeal ileal conduit urinary diversion after robot-assisted radical cystectomy.
    Int J Urol. 2021;28:778-779.
    >> Share

    May 2021
  2. FAN J, Wu K, Zhang N, Yang T, et al
    Green-light laser en bloc resection versus conventional transurethral resection for initial non-muscle-invasive bladder cancer: A randomized controlled trial.
    Int J Urol. 2021 May 19. doi: 10.1111/iju.14592.
    >> Share

  3. MIYATA Y, Matsuo T, Sakai H
    Editorial Comment to Green-light laser en bloc resection versus conventional transurethral resection for initial non-muscle-invasive bladder cancer: A randomized controlled trial.
    Int J Urol. 2021 May 19. doi: 10.1111/iju.14607.
    >> Share

  4. KUROBE M
    Editorial Comment from Dr Kurobe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
    Int J Urol. 2021 May 3. doi: 10.1111/iju.14594.
    >> Share

  5. IQBAL U, Durrani MM, Elsayed AS, Hussein AA, et al
    Functional outcomes after robot-assisted radical cystectomy: A review of literature.
    Int J Urol. 2021;28:493-501.
    >> Share

  6. FARAJ KS, Rose KM, Navaratnam AK, Abdul-Muhsin HM, et al
    Effect of intracorporeal urinary diversion on the incidence of benign ureteroenteric stricture after cystectomy.
    Int J Urol. 2021;28:593-597.
    >> Share

    April 2021
  7. LONATI C, Moschini M
    Editorial Comment from Dr Lonati and Dr Moschini to Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
    Int J Urol. 2021 Apr 22. doi: 10.1111/iju.14577.
    >> Share

  8. URABE F
    Editorial Comment from Dr Urabe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
    Int J Urol. 2021 Apr 21. doi: 10.1111/iju.14580.
    >> Share

  9. SAITO R
    Editorial Comment from Dr Saito to Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Int J Urol. 2021 Apr 21. doi: 10.1111/iju.14588.
    >> Share

  10. KIJIMA T
    Editorial Comment from Dr Kijima to Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
    Int J Urol. 2021 Apr 21. doi: 10.1111/iju.14581.
    >> Share

  11. HAYASHI Y, Fujita K, Banno E, Eich ML, et al
    Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
    Int J Urol. 2021 Apr 15. doi: 10.1111/iju.14574.
    >> Share

  12. YAMASHITA S, Iguchi T, Koike H, Wakamiya T, et al
    Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
    Int J Urol. 2021 Apr 5. doi: 10.1111/iju.14569.
    >> Share

    March 2021
  13. TEOH JY
    Editorial Comment to Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Int J Urol. 2021 Mar 28. doi: 10.1111/iju.14563.
    >> Share

  14. HATANO K, Nonomura N
    Editorial Comment from Dr Hatano and Dr Nonomura to Temporal trends in the incidence of distant-stage bladder cancer among young individuals.
    Int J Urol. 2021 Mar 28. doi: 10.1111/iju.14559.
    >> Share

  15. SETOGUCHI K, Saito K
    Editorial Comment from Dr Setoguchi and Dr Saito to Laparoscopic versus open radical cystectomy in 607 patients with bladder cancer: Comparative survival analysis.
    Int J Urol. 2021 Mar 27. doi: 10.1111/iju.14561.
    >> Share

  16. FUKUSHIMA H
    Editorial Comment from Dr Fukushima to Temporal trends in the incidence of distant-stage bladder cancer among young individuals.
    Int J Urol. 2021 Mar 26. doi: 10.1111/iju.14558.
    >> Share

  17. TAOKA R, Tsunemori H, Matsuoka Y, Kohashiguchi K, et al
    Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Int J Urol. 2021 Mar 19. doi: 10.1111/iju.14548.
    >> Share

  18. HAYAKAWA N, Kikuchi E
    Editorial Comment to Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort.
    Int J Urol. 2021 Mar 18. doi: 10.1111/iju.14557.
    >> Share

  19. MIYAMOTO T, Miyake M, Toyoshima Y, Fujii T, et al
    Clinical outcomes after intravesical bacillus Calmette-Guerin for the highest-risk non-muscle-invasive bladder cancer newly defined in the Japanese Urological Association Guidelines 2019.
    Int J Urol. 2021 Mar 18. doi: 10.1111/iju.14545.
    >> Share

  20. TULLY KH, Reese SW, Cole AP, Noldus J, et al
    Temporal trends in the incidence of distant-stage bladder cancer among young individuals.
    Int J Urol. 2021 Mar 14. doi: 10.1111/iju.14550.
    >> Share

  21. HUANG H, Yan B, Hao H, Shang M, et al
    Laparoscopic versus open radical cystectomy in 607 patients with bladder cancer: Comparative survival analysis.
    Int J Urol. 2021 Mar 13. doi: 10.1111/iju.14537.
    >> Share

  22. KANNO T
    Editorial Comment from Dr Kanno to Laparoscopic versus open radical cystectomy in 607 patients with bladder cancer: Comparative survival analysis.
    Int J Urol. 2021 Mar 13. doi: 10.1111/iju.14551.
    >> Share

  23. KUBOTA M, Kanno T, Inoue T, Yamasaki T, et al
    Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort.
    Int J Urol. 2021 Mar 7. doi: 10.1111/iju.14533.
    >> Share

    February 2021
  24. INOKUCHI J, Kuroiwa K, Nishiyama H, Kojima T, et al
    Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
    Int J Urol. 2021;28:208-214.
    >> Share

    November 2020
  25. NAKAGAWA T
    Lymph node dissection for bladder cancer: Current standards and the latest evidence.
    Int J Urol. 2020 Nov 3. doi: 10.1111/iju.14398.
    >> Share

  26. TANAKA H, Fujii Y
    Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence.
    Int J Urol. 2020 Nov 3. doi: 10.1111/iju.14419.
    >> Share

  27. KOJIMA T
    Editorial Comment from Dr Kojima to Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma.
    Int J Urol. 2020;27:1031.
    >> Share

  28. YOSHIDA T, Matsuda T
    Editorial Comment from Dr Yoshida and Dr Matsuda to Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma.
    Int J Urol. 2020;27:1030-1031.
    >> Share

    September 2020
  29. TAOKA R, Matsuoka Y, Kohashiguchi K, Miura T, et al
    Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer.
    Int J Urol. 2020 Sep 28. doi: 10.1111/iju.14372.
    >> Share

  30. KHETRAPAL P
    Editorial Comment to Benefits of robotic cystectomy compared with open cystectomy in an Enhanced Recovery After Surgery program: A propensity-matched analysis.
    Int J Urol. 2020;27:788-789.
    >> Share

    August 2020
  31. IWASAWA T, Niwa N, Matsumoto K, Komatsuda A, et al
    Reduced recurrence of low-risk non-muscle-invasive bladder cancer is associated with low urine-specific gravity.
    Int J Urol. 2020 Aug 13. doi: 10.1111/iju.14351.
    >> Share

    July 2020
  32. TANAKA H
    Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.
    Int J Urol. 2020 Jul 21. doi: 10.1111/iju.14314.
    >> Share

    June 2020
  33. WEINER AB, Pham MN, Isaacson DS, Ko OS, et al
    Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort.
    Int J Urol. 2020 Jun 26. doi: 10.1111/iju.14288.
    >> Share

  34. MATSUMOTO H, Shiraishi K, Azuma H, Inoue K, et al
    Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.
    Int J Urol. 2020 Jun 21. doi: 10.1111/iju.14281.
    >> Share

  35. SHIN T
    Editorial Comment from Dr Shin to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jun 4. doi: 10.1111/iju.14282.
    >> Share

  36. ADOMI S, Fujita K, Yoshimura K, Uemura H, et al
    Editorial Comment from Dr Adomi et al. to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jun 4. doi: 10.1111/iju.14284.
    >> Share

    May 2020
  37. OKITA K, Hatakeyama S, Momota M, Soma O, et al
    Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 May 25. doi: 10.1111/iju.14263.
    >> Share

    March 2020
  38. MATSUMOTO H, Shiraishi K, Azuma H, Inoue K, et al
    Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper.
    Int J Urol. 2020 Mar 14. doi: 10.1111/iju.14210.
    >> Share

    February 2020
  39. ABE T
    Editorial Comment from Dr Abe to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Feb 5. doi: 10.1111/iju.14193.
    >> Share

  40. TANAKA H, Fujii Y
    Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Feb 5. doi: 10.1111/iju.14194.
    >> Share

    January 2020
  41. TANAKA H, Fukushima H, Kijima T, Nakamura Y, et al
    Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jan 19. doi: 10.1111/iju.14179.
    >> Share

  42. KANNO T, Inoue T, Ito K, Okumura K, et al
    Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Jan 16. doi: 10.1111/iju.14182.
    >> Share

  43. HERR H
    Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guerin?
    Int J Urol. 2020;27:72-74.
    >> Share

    December 2019
  44. KIKUCHI E, Hayakawa N, Fukumoto K, Shigeta K, et al
    Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.
    Int J Urol. 2019 Dec 3. doi: 10.1111/iju.14153.
    >> Share

    October 2019
  45. FUKUHARA H
    Editorial Comment from Dr Fukuhara to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 11. doi: 10.1111/iju.14124.
    >> Share

  46. MATSUMOTO H
    Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
    >> Share

    September 2019
  47. NOHARA T, Kato Y, Nakano T, Nakagawa T, et al
    Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14099.
    >> Share

  48. CHOO SH, Nishiyama H, Kitamura H, Chen CH, et al
    Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14105.
    >> Share

    August 2019
  49. YOSHIDA T, Kates M, Fujita K, Bivalacqua TJ, et al
    Predictive biomarkers for drug response in bladder cancer.
    Int J Urol. 2019 Aug 1. doi: 10.1111/iju.14082.
    >> Share

    July 2019
  50. FUJIMURA T
    Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14076.
    >> Share

  51. TEISHIMA J, Matsubara A
    Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14086.
    >> Share

  52. KOJIMA T
    Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, inductio
    Int J Urol. 2019 Jul 28. doi: 10.1111/iju.14074.
    >> Share

  53. KOBAYASHI T
    Editorial Comment from Dr Kobayashi to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induc
    Int J Urol. 2019 Jul 21. doi: 10.1111/iju.14075.
    >> Share

  54. OSAWA T, Wei JT, Abe T, Kako Y, et al
    Development of the Japanese version of the health-related quality of life questionnaire for bladder cancer patients using the Bladder Cancer Index: A pilot study.
    Int J Urol. 2019 Jul 16. doi: 10.1111/iju.14073.
    >> Share

  55. TOIDE M, Yokoyama M, Fujiwara M, Kijima T, et al
    Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cyst
    Int J Urol. 2019 Jul 8. doi: 10.1111/iju.14054.
    >> Share

    March 2019
  56. NAKAYAMA M, Ito Y, Hatano K, Nakai Y, et al
    Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan.
    Int J Urol. 2019 Mar 27. doi: 10.1111/iju.13955.
    >> Share

  57. LEE A, Lee HJ, Huang HH, Ho H, et al
    Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13913.
    >> Share

  58. ZACHOS I
    Editorial Comment to Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13929.
    >> Share

    February 2019
  59. YASUI M, Kawahara T, Takamoto D, Izumi K, et al
    Distribution of androgen receptor expression in the urinary bladder.
    Int J Urol. 2019;26:305-306.
    >> Share

    January 2019
  60. KOIE T, Ohyama C, Makiyama K, Shimazui T, et al
    Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13900.
    >> Share

  61. TEISHIMA J, Matsubara A
    Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13906.
    >> Share

  62. MIYATA Y, Matsuo T, Sakai H
    Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2019 Jan 22. doi: 10.1111/iju.13893.
    >> Share

    December 2018
  63. HASHIMOTO T
    Editorial Comment from Dr Hashimoto to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2018 Dec 16. doi: 10.1111/iju.13889.
    >> Share

  64. NAKATA W, Yamamichi G, Tsujimura G, Tsujimoto Y, et al
    Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2018 Dec 2. doi: 10.1111/iju.13880.
    >> Share

    November 2018
  65. MIYAKE M, Nakai Y, Hori S, Morizawa Y, et al
    Transient liver toxicity as a result of the oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2018 Nov 18. doi: 10.1111/iju.13856.
    >> Share

    October 2018
  66. ADELOYE D, Harhay MO, Ayepola OO, Dos Santos JP, et al
    Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis.
    Int J Urol. 2018 Oct 21. doi: 10.1111/iju.13824.
    >> Share

  67. MIYAKE M, Hori S, Owari T, Morizawa Y, et al
    Animal model of local tumor recurrence after resection using the murine MBT2 bladder cancer cell line in syngeneic C3H mice.
    Int J Urol. 2018 Oct 16. doi: 10.1111/iju.13834.
    >> Share

    July 2018
  68. OHTAKA M, Kawahara T, Ishiguro Y, Sharma M, et al
    Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer.
    Int J Urol. 2018 Jul 24. doi: 10.1111/iju.13756.
    >> Share

  69. ZHANG D, Zhou C, Li Y, Gao L, et al
    Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Int J Urol. 2018 Jul 18. doi: 10.1111/iju.13726.
    >> Share

  70. NAKAI Y, Inoue K, Tsuzuki T, Shimamoto T, et al
    Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13718.
    >> Share

  71. YANG J, Zhang P, Zhou H, Feng S, et al
    Prospective, randomized controlled study of the preventive effect of fosfomycin tromethamine on post-transurethral resection of bladder tumor urinary tract infection.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13719.
    >> Share

    March 2018
  72. MIYAZAKI J, Onozawa M, Takaoka E, Yano I, et al
    Bacillus Calmette-Guerin strain differences as the basis for immunotherapies against bladder cancer.
    Int J Urol. 2018 Mar 5. doi: 10.1111/iju.13538.
    >> Share

  73. TATSUGAMI K
    Editorial Comment to Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2018;25:218-219.
    >> Share

    February 2018
  74. OTTO W, van Rhijn BW, Breyer J, Bertz S, et al
    Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer.
    Int J Urol. 2018 Feb 22. doi: 10.1111/iju.13532.
    >> Share

    December 2017
  75. FUJII Y
    Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Dec 16. doi: 10.1111/iju.13509.
    >> Share

  76. OHNO Y
    Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Dec 7. doi: 10.1111/iju.13506.
    >> Share

    November 2017
  77. YANG X, Shi L, Yi C, Yang Y, et al
    Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Int J Urol. 2017 Nov 8. doi: 10.1111/iju.13486.
    >> Share

  78. TAN YG, Eu EWC, Huang HH, Lau WKO, et al
    High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13480.
    >> Share

    July 2017
  79. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    >> Share

  80. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    >> Share

  81. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    >> Share

    March 2017
  82. SHIMIZU F, Muto S, Taguri M, Ieda T, et al
    Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Int J Urol. 2017 Mar 9. doi: 10.1111/iju.13324.
    >> Share

    February 2017
  83. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    >> Share

    January 2017
  84. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13290.
    >> Share

  85. MATSUMURA N, Nakamura Y, Kohjimoto Y, Nishizawa S, et al
    Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
    Int J Urol. 2017 Jan 9. doi: 10.1111/iju.13274.
    >> Share

    December 2016
  86. ALEVIZOPOULOS A, Tyritzis S, Leotsakos I, Anastasopoulou I, et al
    Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Int J Urol. 2016 Dec 22. doi: 10.1111/iju.13271.
    >> Share

  87. BESIROGLU H
    Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
    >> Share

    November 2016
  88. REIS LO
    Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016;23:963.
    >> Share

    October 2016
  89. VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
    Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
    >> Share

  90. HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
    Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
    Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
    >> Share

    April 2016
  91. DAL MORO F, Zattoni F
    Lighting from the urethral cystoscope side: A novel technique to safely manage bowel division during intracorporeal robotic urinary diversion.
    Int J Urol. 2016;23:344-5.
    >> Share

  92. JINZAKI M, Kikuchi E, Akita H, Sugiura H, et al
    Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Int J Urol. 2016;23:284-98.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016